Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded quarterly Other financing activities of $5.0 million in Q1 2026, up 600.0% quarter-over-quarter from -$1.0 million in Q1 2024.
Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Other financing activities history runs 2 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed N/A YoY), while the FY2024 annual figure was $2.0 million, changed N/A from the prior year.
- Other financing activities was $5.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$1.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $5.0 million in Q1 2026 to a low of -$1.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |